Webcast: Genomic Medicine in Breast & Ovarian Cancer

My good friend, Steve Murphy, is going to come up with something interesting again. Helix Health, the first stand alone genomic medicine practice in the US, will host a free 90-minute webcast on the 21st of May, 2008 from 1:00-2:30 PM EDT on:

How Genomic Medicine Is Changing the Management of Breast & Ovarian Cancer

Click here to register.

Every hour, 150 people in the United States are diagnosed with cancer. Yet today, there are a growing number of people who are not waiting to hear that diagnosis. They are undergoing genetic testing to determine whether they have a genetic predisposition to the disease.

That’s exactly what Jessica Queller, author of Pretty Is What Changes, did after her mother, a breast cancer survivor, died of ovarian cancer. Jessica tested positive for the BRCA1 gene mutation and faced a most difficult decision. Jessica will join David Ewing Duncan, bestselling author of Masterminds: Genius, DNA
and the Quest to Rewrite Life, and a panel of distinguished medical and legal professionals to discuss how the doctor-patient relationship is changing and what the potential liability is for physicians in this new era of breast & ovarian cancer and genomic medicine.

What should a doctor and patient do when a patient tests positive?
What is the risk in taking a “wait and see” approach?
Are there alternatives to radical surgery?
What are potential tort issues in predictive genetic testing and medical uses of
genetic tests?